Skip Navigation LinksHome > February 2008 - Volume 108 - Issue 2 > The Common Inhalational Anesthetic Isoflurane Induces Apopto...
doi: 10.1097/01.anes.0000299435.59242.0e
Laboratory Investigations

The Common Inhalational Anesthetic Isoflurane Induces Apoptosis via Activation of Inositol 1,4,5-Trisphosphate Receptors

Wei, Huafeng M.D., Ph.D.*; Liang, Ge M.D.†; Yang, Hui M.D.‡; Wang, Qiujun M.D.§; Hawkins, Brian Ph.D.∥; Madesh, Muniswamy Ph.D.#; Wang, Shouping M.D.**; Eckenhoff, Roderic G. M.D.††

Free Access
Article Outline
Collapse Box

Author Information

Collapse Box


Background: Isoflurane induces cell apoptosis by an unknown mechanism. The authors hypothesized that isoflurane activates inositol 1,4,5-trisphosphate (IP3) receptors on the endoplasmic reticulum (ER) membrane, causing excessive calcium release, triggering apoptosis.
Methods: The authors determined isoflurane-induced cytotoxicity by measuring caspase-3 activity, lactate dehydrogenase release, MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) reduction, and imaging analysis of cell damage markers (annexin V and propidium iodide staining) in different cell types. The authors used the chicken B lymphocyte with a total knock-out of IP3 receptors, PC12 cells with elevated IP3 receptor activity (transfected with L286V presenilin 1), striatal cells with a knock-in of Q111 Huntingtin, and each cell line’s corresponding wild-type controls. The authors also measured the isoflurane-evoked changes of calcium concentration in cytosol and/or mitochondria in these cells.
Results: Isoflurane induced apoptosis concentration- and time-dependently, and sequentially elevated cytosolic and then mitochondrial calcium in the chicken B-lymphocyte wild-type but not the IP3 receptor total knock-out cells. Thapsigargin, a calcium adenosine triphosphatase inhibitor on ER membranes, induced apoptosis and elevations of calcium in cytosol and mitochondria in both chicken B-lymphocyte wild-type and IP3 receptor total knock-out cells. Isoflurane induced significantly more neurotoxicity and greater calcium release from the ER in L286V PC12 and Q111 Huntingtin striatal cells than in their corresponding wild-type controls, both of which were significantly inhibited by the IP3 receptor antagonist xestospongin C.
Conclusion: These findings suggest that isoflurane activates the ER membrane IP3 receptor, producing excessive calcium release and triggering apoptosis. Neurons with enhanced IP3 receptor activity, as in certain cases of familial Alzheimer or Huntington disease, may be especially vulnerable to isoflurane cytotoxicity.
THE common inhalational anesthetic isoflurane induces cytotoxicity in both a concentration- and time-dependent manner in different types of cultured cells.1–8 Further, at clinically relevant concentrations, isoflurane caused widespread neuronal apoptosis in developing rat brains with subsequent persistent learning deficits.9,10 Isoflurane also caused cognitive dysfunction persisting for several weeks after treatment in adult and aged rats11,12 and aged mice.13 Therefore, it is possible that general anesthesia may contribute to the recently reported cognitive deficits after surgery, especially in aged patients.14,15
The inositol 1,4,5-trisphosphate (IP3) receptors, found in the endoplasmic reticular (ER) membrane, play an important role in both normal physiology16 and pathologic neurodegeneration.17,18 Excessive calcium release from the ER, via overactivation of IP3 receptors, results in elevation of cytosolic calcium concentration ([Ca2+]c), calcium overload in mitochondria, and depletion of ER calcium, all of which can contribute to cell death.19,20 In addition, cytochrome c released from mitochondria due to calcium overload removes the negative feedback inhibition of IP3 receptors by cytosolic calcium, leading to a vicious cycle of excessive calcium release from the ER via IP3 receptors.17,20 Cytochrome c release also activates caspase 3, which in turn cleaves IP3 receptors, resulting in a permanent leak of calcium from the ER.21 Predictably, cells deficient in IP3 receptors demonstrate resistance to apoptosis induced by a variety of injuries.22 Over activation of IP3 receptors is implicated in the neurodegeneration seen in diseases such as Alzheimer disease and Huntington disease (HD) and in conditions such as stroke.18,19,23,24
The mechanisms of isoflurane neurotoxicity are unknown. Our previous work has demonstrated that dantrolene, an ER ryanodine receptor antagonist, inhibited isoflurane-induced apoptosis,1 suggesting a role for abnormal calcium release from the ER in isoflurane neurotoxicity. In neurons, isoflurane may induce calcium release from the ER, although it is not clear whether this is the result of actions on the IP3 or the ryanodine receptor.25 We hypothesized in the current study that isoflurane induces apoptosis by excessive calcium release from ER via overactivation of IP3 receptor. To test this hypothesis, we studied apoptosis and calcium release from the ER in a variety of cell types with varying IP3 receptor expression or activity.
Back to Top | Article Outline

Materials and Methods

Cell Cultures
Cells of wild-type (WT) chicken B lymphocyte (DT40) cell line, and its total IP3 receptor knock-out (DT40 IP3R TKO) type, were cultured in RPMI 1640 with 10% fetal calf serum, 1% chicken serum, 50 μm 2-mercaptoethanol, 4 mm l-glutamine, and antibiotics in a 95% air, 5% CO2 humidified atmosphere at 38°C as previously described.26 Rat pheochromocytoma (PC12) cells transfected with WT presenilin 1 (PS1) or point mutated PS1 (L286V) were cultured in Dulbecco’s Modified Eagle’s Medium supplemented with 10% heat-inactivated horse serum, 5% fetal calf serum, 200 μg/ml G418, and antibiotics in a 95% air, 5% CO2 humidified atmosphere at 37°C as described.1,27 The transfection of the WT and mutant PS1 has been described and confirmed in detail previously.28,29 Mouse HD knock-in striatal cells (STHdhQ111/Q111) and their WT control cells (STHdhQ7/Q7) were generated and cultured as described previously.30,31 Briefly, cells were cultured in Dulbecco’s Modified Eagle’s Medium supplemented with 10% fetal calf serum, 400 μg/ml G418, and antibiotics in a 95% air, 5% CO2 humidified atmosphere at 33°C.
Back to Top | Article Outline
Anesthetic Exposure
DT40 cells (WT and IP3R TKO), rat PC12 cells (WT and L286V), and mouse striatal cells (WT and HD) were exposed to isoflurane at different concentrations for various durations in a gastight chamber inside the culture incubator (Bellco Glass, Inc., Vineland, NJ), with humidified 5% CO2–21% O2–balanced N2 (AirGas East, Bellmawr, NJ) going through a calibrated agent-specific vaporizer as described previously.1 Gas phase concentrations in the gas chamber were verified and maintained at the desired concentration throughout the experiments using an infrared Ohmeda 5330 agent monitor (Coast to Coast Medical, Fall River, MA). In a pilot study, the cell medium was aspirated and extracted into hexane for high-performance liquid chromatography measurement (System Gold; Beckman Coulter, Fullerton, CA) to verify that the various anesthetic concentrations in the medium in millimolars are equivalent to the minimal alveolar concentration (MAC) in the gas phase inside the gas chamber using the concentration correlation previously described.32
Back to Top | Article Outline
Imaging Analysis of Annexin V and Propidium Iodide
Translocation of membrane phospholipid phosphatidylserine from the inner to the outer leaflet of the plasma membrane is an early indication of cell damage. Annexin V, a phospholipid binding protein with a high affinity for phospholipid phosphatidylserine, can bind to phospholipid phosphatidylserine once it is exposed to the extracellular environment. Propidium iodide (PI) can bind to nucleic acid after penetrating a breached plasma membrane, as occurs in the later stages of cell damage. We treated DT40 cells, grown floating in the medium, with different concentrations of isoflurane (0.6, 1.2, and 2.4%) for 24 h, as well as with 2.4% isoflurane for different times (6, 12, and 24 h). Immediately after treatment, we determined annexin V– or PI–positive cells by the methods described previously.26 Cells were dropped onto 25-mm cover slips and stained with annexin V or PI. The stained cells were visualized and counted by two persons blinded to the treatments. The percentage of annexin V– or PI–positive cells averaged from four areas on each cover slip was then calculated and compared.
Back to Top | Article Outline
Detection of Caspase-3 Activity
Increased caspase-3 activity is a typical marker for apoptosis. The assay is based on the ability of the active enzymes to cleave the fluorogenic substrates Ac-DEVD-AFC (caspase 3; Calbiochem, San Diego, CA) and was performed as per instructions and as described previously.26 DT40 cells grown on six well plates were treated with 2.4% isoflurane for 24 h and then were harvested via trypsinization and washed with phosphate-buffered saline. The cell pellet was gently resuspended in CelLytic M lysis buffer and protease inhibitor cocktail (Sigma, St. Louis, MO), lysed, and centrifuged; the supernatant was used for the assay. Caspase substrates were added to a final concentration of 50 μm, and the samples were incubated at 37°C for 45 min in caspase assay buffer. Incubated samples were measured at an excitation of 400 nm and an emission of 505 nm in a multiwavelength-excitation dual wavelength-emission fluorometer (Delta RAM; photon Technology International, Birmingham, NJ). We determined the caspase-3 activity immediately after treating DT40 cells with 2.4% isoflurane for 24 h.
Back to Top | Article Outline
Cytotoxicity Assays
The inhibition of isoflurane-induced cytotoxicity by xestospongin C, a potent antagonist of IP3 receptor, was assessed by the lactate dehydrogenase (LDH) release assay in PC12 cells and MTS (3-(4,5-dimethylthiazol-2-yl)- 5-(3carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) reduction assay in mouse striatal cells. LDH release reflects plasma membrane integrity, is a relatively late event in cytotoxicity, and is shared by both apoptosis and necrosis pathways, and its measurement is well described.1 The MTS reduction assay reflects mitochondrial function and is considered a middle event in both apoptosis and necrosis. The tetrazolium compound is bioreduced by normal mitochondria into a colored formazan product measured by absorbance. We followed the standard experimental protocol for MTS reduction assay from Promega (Madison, WI). We treated PC12 and striatal neurons, grown on 24 well plates, with 2.4% isoflurane for 24 h. Immediately (PC12 cells) or 24 h (striatal neurons) after treatment, LDH or MTS assay was performed, respectively. Xestospongin C at 100 nm was used to inhibit IP3 receptor activity. The results of LDH release and MTS reduction assays were expressed as a percentage of the control without anesthetic treatment.
Back to Top | Article Outline
Simultaneous Confocal Imaging of Cytosolic and Mitochondrial Ca2+
The method used was the same as described previously.26 DT40 cells (WT and IP3R TKO) grown on 25-mm cover slips were loaded with 2 μm rhod-2/AM in cell medium containing 2.0% bovine serum albumin in the presence of 0.003% Pluronic acid at 37°C for 50 min. Cells loaded with rhod-2 dye were washed and then reloaded with fluo-4/AM for an additional 30 min at room temperature. Cells were placed on a stage and exposed to 2 MAC (0.7 mm) isoflurane dissolved in the perfusion buffer. The images were recorded using the Radiance 200 imaging system with excitation at 488 and 568 nm for fluo-4 and rhod-2, respectively.
Back to Top | Article Outline
Measurement of Cytosolic Calcium Concentration
Cytosolic calcium concentration was measured using fura-2 fluorescence (Molecular Probes, Eugene, OR) with a photometer coupled to an Olympus 1Χ70 inverted microscope (Olympus America Inc., Center Valley, PA) and IPLab version 3.7 imaging processing and analysis software (Biovision Technologies, Exton, PA). The protocol to determine [Ca2+]c was similar to that previously described, with some modifications.33 Briefly, cells grown on 25-mm round glass cover slips were washed three times with Krebs-Ringer’s buffer without addition of calcium and then loaded with 2.5 μm fura-2/AM (Molecular Probes) for 30 min at room temperature. The cells were then placed in a sealed chamber (Warner Instrument Inc., Hamden, CT) connected with multiple inflow infusion tubes and one outflow tube, which provided constant flow to the chamber. The cells were first washed with Krebs-Ringer’s buffer through one inflow tube for the baseline measurement of [Ca2+]c, and then were exposed to isoflurane via a separate inflow infusion tubes driven by a syringe pump (Braintree Scientific Inc., Braintree, MA). The fluorescence signals were measured with excitation at 340 and 380 alternatively and emission at 510 nm for a period up to 18 min for each treatment. A pilot study confirmed that the cells were still viable at the end of experiments for calcium measurement. The fluorescence measurements were calibrated by bathing cells in the HEPES buffer containing ionomycin 20 mm for maximum or 20 mm EGTA for minimum calcium values. The intracellular calcium concentration ([Ca2+]i) was calculated by the ratio method of Grynkiewicz et al.,34 using 224 nm as the Kd of fura-2. The final result of [Ca2+]c was averaged from the cells of at least three separate experiments. We used 0.7 mm (2 MAC) isoflurane to elevate [Ca2+]c in all cells. Xestospongin C at 1 μm was used to inhibit isoflurane-mediated calcium release from the ER.
Back to Top | Article Outline
We used GraphPad Prism 4 software (GraphPad Software, Inc., San Diego, CA) and STATA version 7 Software (StataCorp LP, College Station, TX) for all statistical analysis. Annexin V and PI staining, LDH release, and MTS reduction were all expressed as percentage of those in the control. Peak [Ca2+]c in PC12 and HD striatum cells was expressed as a percentage of its own baseline. We analyzed the data with one-way analysis of variance followed by Newman-Keuls multiple comparison tests using GraphPad Prism. We also confirm our analysis of dose response and time response of image analysis of cell damage marker annexin V and PI in DT40 cells with a mixed mode of regression using STATA version 7. A significantly increased odds ratio risk was determined if the estimate for the greater time point or dose exceeded the upper limit of the 95% confidence interval for the lower time point or dose. P < 0.05 was considered statistically significant.
Back to Top | Article Outline


DT40 IP3R TKO Cells Were Resistant to Isoflurane-induced Apoptosis
Fig. 1
Fig. 1
Image Tools
Fig. 2
Fig. 2
Image Tools
To investigate whether isoflurane induces apoptosis in the absence of IP3 receptors, we first studied its cytotoxic effects in the DT40 IP3R TKO cells and compared it with the corresponding WT cells. Isoflurane induced cell damage determined by both annexin V and PI staining concentration-dependently in WT but not in IP3R TKO cells (figs. 1A–C). The lowest concentration of isoflurane required to induce apoptosis in WT cells was 1.2% (figs. 1B and C), a clinically used concentration. Isoflurane also induced cell damage time-dependently in WT but not TKO cells (figs. 1D–F). In WT cells, 2.4% isoflurane induced early cell damage in as little as 6 h of treatment (fig. 1E), a duration often used for surgeries. To confirm that isoflurane induced cell damage in DT40 cells by apoptosis, we measured changes of caspase-3 activity after exposing these cells to 2.4% isoflurane for 24 h. Isoflurane caused a dramatic elevation (more than fourfold) of caspase-3 activity in DT40 WT but not IP3R TKO cells (fig. 2A).
Back to Top | Article Outline
Isoflurane-induced Apoptosis Was Associated with Elevation of [Ca2+]c and Then [Ca2+]m in DT40 WT but Not IP3R TKO Cells
To further examine the hypothesis that isoflurane induced apoptosis by disruption of intracellular calcium homeostasis, we first assayed the cytotoxic effects of thapsigargin, a selective inhibitor of the ER calcium adenosine triphosphatase, which can cause ER calcium to passively leak even without any contribution from IP3 receptors.35 Thus, in this positive control experiment, thapsigargin (100 nm for 2 h) induced similar apoptosis in both WT and TKO cells (fig. 2B), whereas 2.4% isoflurane for 24 h only induced apoptosis in DT40 WT cells. Isoflurane induced a sequential elevation of [Ca2+]c and then mitochondria calcium concentration ([Ca2+]m) only in DT40 WT but not TKO cells (figs. 2C and D), whereas thapsigargin produced this sequential calcium elevation in both WT and IP3R TKO cells (fig. 2E). These results show that the IP3 receptor knock-out did not diminish the cells response to stress or calcium transients in general, and thereby strengthen the hypothesis that isoflurane induced apoptosis by causing calcium release from the ER via overactivation of IP3 receptors.
Back to Top | Article Outline
Elevated Activity of IP3 Receptors Enhances Isoflurane-induced Apoptosis
Fig. 3
Fig. 3
Image Tools
The mutation of PS1, a protein located primarily on ER membranes, appears in most cases of familial Alzheimer disease, and is associated with increased expression of ryanodine receptors27 and increased activity of IP3 receptors.36,37 If isoflurane induces apoptosis by overactivation of IP3 receptor, cells with enhanced expression or activity of this receptor should be more vulnerable to isoflurane-induced cytotoxicity and exhibit greater calcium release from the ER. Consistent with this hypothesis, isoflurane caused significantly more PI-positive cells in PC12 cells transfected with L286V PS1 than in its WT vector control (figs. 3A and B). To establish the linkage of these cytotoxic effects of isoflurane to IP3 receptors, we coincubated cells with xestospongin C, a potent inhibitor of the IP3 receptor.38,39 Xestospongin C abolished the cell damage represented by elevated LDH (fig. 3C) and also nearly abolished the calcium release from the ER caused by isoflurane (figs. 3D and E) in L286V PC12 cells. Although xestospongin C may also inhibit calcium adenosine triphosphatase in some cell cultures,40 it did not affect adenosine triphosphatase activity in this system because xestospongin C alone did not increase [Ca2+]c in L286V PC12 cells (data not shown).
Fig. 4
Fig. 4
Image Tools
We also examined isoflurane effects in another model of elevated IP3 receptor activity. Abnormal calcium release from ER via elevated activity of IP3 receptors is thought to play an important role in the neurodegeneration of HD.23,41,42 Mutated Huntingtin protein with an enlarged polyglutamine repeat section causes excessive calcium release from the ER upon the activation of IP3 receptors by an agonist.23 Therefore, if isoflurane causes apoptosis via activation of IP3 receptors, the elevated activity of IP3 receptors in mouse striatal cells with an overexpression of Q111 Huntingtin should not only render these cells more vulnerable to isoflurane-induced neurotoxicity and calcium release from the ER, but also xestospongin C should inhibit these effects. In accordance with this hypothesis, 2.4% isoflurane for 24 h induced more cell damage (PI-positive cells) in Q111 Huntingtin knock-in than in the corresponding WT control striatal cells (figs. 4A and B), and xestospongin C (100 nm) abolished this cytotoxic effect (fig. 4C). In the absence of extracellular calcium, 2.4% isoflurane (0.7 mm) induced significantly greater elevation of [Ca2+]c (representing calcium release from the ER) in Q111 Huntingtin knock-in than the WT control striatal cells, an effect that was also nearly abolished by pretreatment of xestospongin C (figs. 4D and E).
Back to Top | Article Outline


Our results are most consistent with the hypothesis that isoflurane, a commonly used inhalational anesthetic, induces cell apoptosis by excessive calcium release from the ER via overactivation of IP3 receptors. First, cells depleted of IP3 receptors were resistant to isoflurane-induced apoptosis and calcium elevation, whereas cells with enhanced activity of the IP3 receptor were more vulnerable to isoflurane-induced apoptosis. Finally, the IP3 receptor antagonist xestospongin C significantly inhibited isoflurane-induced cell damage and calcium elevations in the vulnerable cell models.
Our results suggest a direct interaction between isoflurane and the receptor protein, but cannot prove it. Alternative possibilities are that isoflurane interacts with an associated protein or signaling system, or the ER lipid membrane itself. But it has been demonstrated that anesthetics similar to isoflurane can bind specifically to many membrane proteins,43 so it is plausible that the effect on IP3 receptors may be the result of a direct interaction.
Consistent with our previous study and others,1,44 isoflurane induced apoptosis in DT40 WT cells concentration- and time-dependently. It is important to note that there exists considerable variation in cell sensitivity to isoflurane-induced apoptosis. For example, the minimal time to induce apoptosis in DT40 cells with 2.4% isoflurane was only 6 h, with a minimal concentration of 1.2%. In rat cerebral cortical neurons or PC12 cells, the minimal concentration and time needed to induce apoptosis was 2.4% isoflurane for 24 h.1 Immortalized striatal neurons also needed a minimal exposure of 2.4% isoflurane for 24 h to induce modest cell damage in this study. In normal human peripheral lymphocytes, only 0.85% isoflurane was needed to induce apoptosis,44 and it is likely that normal human neurons are similarly sensitive. Although this study suggests that the IP3 receptor is an important target underlying isoflurane-induced apoptosis, this variability in sensitivity suggests that there may be other targets that contribute, or that downstream effects are considerably different. In addition, the shortest times for 2.4% isoflurane to induce apoptosis in chicken lymphocytes are 6 h (fig. 1E) and 12 h (fig. 1F), respectively, when techniques to detect early-phase (annexin V) apoptosis or late-phase (PI staining, primarily necrosis) cell damage were used. This demonstrates that the detection of vulnerability to isoflurane cytotoxicity will vary depending on the assays used to measure cell damage. Isoflurane may produce only modestly enhanced LDH release in PS1 mutated PC12 cells (fig. 3C) because the LDH method detects severe late cell damage, whereas the cell injury induced by these concentrations of isoflurane must be more subtle, given the lack of overt clinical sequelae. Further studies are needed to determine the features that underlie this differing vulnerability to isoflurane-induced toxicity.
Increased calcium release from the ER via the IP3 receptors may contribute to neurodegeneration in other conditions, such as Alzheimer disease and HD.36,37,45 Various mutations of PS1, a protein located primarily in ER membranes, appear in most cases of familial Alzheimer disease. This PS1 mutation has been associated with increased activity of the IP3 receptors,36,37 which may render neurons more vulnerable to apoptosis induced by a variety of factors that trigger calcium release (e.g., excitotoxicity). Our results are consistent with this hypothesis in that PC12 with L286V PS1 were more vulnerable to isoflurane cytotoxicity than its WT control, in a xestospongin C–dependent manner. It should be noted that many other PS1 mutations, such as PS1 delta 9, M146V, or just enhanced expression of full-length PS1, have been shown to contribute to cell apoptosis.46–48 If these other mutations enhance IP3 receptor activity, our data would predict enhanced vulnerability to isoflurane cytotoxicity. Isoflurane may contribute to pathogenesis via other mechanisms as well. For example, isoflurane has been recently reported to increase β-amyloid production, aggregation, and neurotoxicity2,6,8 and may be associated with tau hyperphosphorylation.49 Thus, there is a growing concern regarding the use of isoflurane in patients with symptoms of, or vulnerabilities to, neurodegenerative disease. Although the connection between polyglutamine-containing proteins and IP3 receptors is not yet clear, the observations with respect to isoflurane are analogous.
It is not yet clear whether all anesthetics activate IP3 receptors. Sevoflurane, a relatively new inhalational anesthetic, did not induce similar neuronal apoptosis as isoflurane at equipotent concentrations,1 so there is hope that other anesthetic drugs might prove to be less neurotoxic, at least in in vitro studies. Clinical studies are ultimately required to demonstrate whether these cell culture studies have any relevance to humans.
It should be noted that isoflurane has been long considered an agent for cardioprotection and neuroprotection.50–52 It is likely that isoflurane is both neurotoxic and neuroprotective, depending on the concentration and duration of exposure, and the degree of patient vulnerability. Isoflurane may be inherently cytotoxic, but it provides cardioprotection or neuroprotection via a preconditioning mechanism, much like hypoxia. Mild calcium release from the ER and moderate elevation of [Ca2+]c by isoflurane at low concentrations and short duration may trigger the ER stress response, marked by the expression of genes characterizing the well-known “preconditioning” effect.53,54 Longer exposures to isoflurane, producing extensive and prolonged calcium release from ER, may deplete ER calcium and shut down protein synthesis, leading to “cytotoxicity” effects.1,55,56 Therefore, like ischemic preconditioning, isoflurane for short durations might provide cytoprotection via preconditioning, whereas prolonged exposures produce cytotoxicity directly. This hypothesis was supported by our recent experiments, which demonstrated that 2.4% isoflurane preconditioning for 1 h abolished neurotoxicity induced by isoflurane itself for 24 h in cerebral cortical neurons.57 These potential dual features of isoflurane should be considered in future studies, and perhaps in clinical application in vulnerable populations.
This study has several limitations that should influence in vivo interpretations: (1) The cells with total IP3R knock-out are chicken B lymphocytes, not neurons. Although the ER calcium handling mechanisms are thought to be the same, downstream effects of the calcium transients might be considerably different. To our knowledge, there are no immortal neuronal cell lines with IP3R knock-out, but transgenic mice with type I IP3R58 or type II and III59 knock-out have been reported, from which cultures of primary neurons could be studied. Expression of IP3 receptors could also be reduced via small interfering RNA in normal neurons. (2) All of the results from this study are from cell lines, which are immortal transformed cells. Although clearly different from normal cells, in general, such cells are more resistant to stressors, making the results of our study somewhat more relevant to the in vivo situation. Future in vivo studies are needed to investigate whether IP3R also plays a role in isoflurane-mediated neurotoxicity in animals or patients.
Taken together, our findings suggest that the commonly used inhalational anesthetic isoflurane may induce cell apoptosis by triggering abnormal calcium release from the ER via activation of IP3 receptors. Preexisting genetic features may render some populations at increased risk from this effect.
The authors thank Mark P. Mattson, Ph.D. (Chief), and Sic L. Chan, Ph.D. (Senior Research Fellow, Laboratory of Neurosciences, National Institute on Aging, Baltimore, Maryland), for providing PC12 cells transfected with Presenilin-1 mutation; Marcy MacDonald, Ph.D. (Associate Professor, Molecular Neurogenetics Unit, Center for Human Genetic Research, Harvard University, Boston, Massachusetts), for providing striatal cells with knocked-in mutated Huntingtin protein; and Tomohiro Kurosaki, M.D., Ph.D. (Professor, Institute of Physical and Chemical Research, Research Center for Allergy and Immunology, Turumi-ku, Yokohama, Kanagawa, Japan), for providing total IP3 receptor knock-out chicken lymphocytes. The authors appreciate the technical support from Qingcheng Meng, Ph.D. (Senior Research Scientist), statistical analysis by Adam Burkey, M.D. (Assistant Professor), and the editing contributions of Christopher Ward, M.D. (Anesthesia Resident, Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, Pennsylvania). The authors also appreciate the discussions with Randall Pittman, Ph.D. (Professor at the Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania).
Back to Top | Article Outline


1. Wei H, Kang B, Wei W, Liang G, Meng QC, Li Y, Eckenhoff RG: Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res 2005; 1037:139–47

2. Eckenhoff RG, Johansson JS, Wei H, Carnini A, Kang B, Wei W, Pidikiti R, Keller JM, Eckenhoff MF: Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology 2004; 101:703–9

3. Kim H, Oh E, Im H, Mun J, Yang M, Khim JY, Lee E, Lim SH, Kong MH, Lee M, Sul D: Oxidative damages in the DNA, lipids, and proteins of rats exposed to isofluranes and alcohols. Toxicology 2006; 220:169–78

4. Kvolik S, Glavas-Obrovac L, Bares V, Karner I: Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci 2005; 77:2369–83

5. Loop T, Dovi-Akue D, Frick M, Roesslein M, Egger L, Humar M, Hoetzel A, Schmidt R, Borner C, Pahl HL, Geiger KK, Pannen BH: Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. Anesthesiology 2005; 102:1147–57

6. Xie Z, Dong Y, Maeda U, Alfille P, Culley DJ, Crosby G, Tanzi RE: The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology 2006; 104:988–94

7. Xie Z, Dong Y, Maeda U, Moir R, Inouye SK, Culley DJ, Crosby G, Tanzi RE: Isoflurane-induced apoptosis: A potential pathogenic link between delirium and dementia. J Gerontol A Biol Sci Med Sci 2006; 61:1300–6

8. Xie Z, Dong Y, Maeda U, Moir RD, Xia W, Culley DJ, Crosby G, Tanzi RE: The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci 2007; 27:1247–54

9. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF: Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23:876–82

10. Ma D, Williamson P, Januszewski A, Nogaro MC, Hossain M, Ong LP, Shu Y, Franks NP, Maze M: Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain. Anesthesiology 2007; 106:746–53

11. Culley DJ, Baxter MG, Yukhananov R, Crosby G: Long-term impairment of acquisition of a spatial memory task following isoflurane–nitrous oxide anesthesia in rats. Anesthesiology 2004; 100:309–14

12. Culley DJ, Baxter M, Yukhananov R, Crosby G: The memory effects of general anesthesia persist for weeks in young and aged rats. Anesth Analg 2003; 96:1004–9

13. Bianchi SL, Tran T, Liu C, Lin S, Li Y, Keller JM, Eckenhoff RG, Eckenhoff MF: Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics [published on-line ahead of print March 6, 2007]. Neurobiol Aging

14. Abildstrom H, Rasmussen LS, Rentowl P, Hanning CD, Rasmussen H, Kristensen PA, Moller JT: Cognitive dysfunction 1–2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand 2000; 44:1246–51

15. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, Langeron O, Johnson T, Lauven PM, Kristensen PA, Biedler A, van Beem H, Fraidakis O, Silverstein JH, Beneken JE, Gravenstein JS: Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998; 351:857–61

16. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 1993; 361:315–25

17. Sedlak TW, Snyder SH: Messenger molecules and cell death: Therapeutic implications. JAMA 2006; 295:81–9

18. Banerjee S, Hasan G: The InsP3 receptor: Its role in neuronal physiology and neurodegeneration. Bioessays 2005; 27:1035–47

19. Lindholm D, Wootz H, Korhonen L: ER stress and neurodegenerative diseases. Cell Death Differ 2006; 13:385–92

20. Hanson CJ, Bootman MD, Roderick HL: Cell signalling: IP3 receptors channel calcium into cell death. Curr Biol 2004; 14:R933–5

21. Assefa Z, Bultynck G, Szlufcik K, Nadif KN, Vermassen E, Goris J, Missiaen L, Callewaert G, Parys JB, De Smedt H: Caspase-3-induced truncation of type 1 inositol trisphosphate receptor accelerates apoptotic cell death and induces inositol trisphosphate-independent calcium release during apoptosis. J Biol Chem 2004; 279:43227–36

22. Jayaraman T, Marks AR: T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol Cell Biol 1997; 17:3005–12

23. Tang TS, Tu H, Chan EY, Maximov A, Wang Z, Wellington CL, Hayden MR, Bezprozvanny I: Huntingtin and Huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 2003; 39:227–39

24. Paschen W, Mengesdorf T: Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease: Therapeutic potential. Pharmacol Ther 2005; 108:362–75

25. Kindler CH, Eilers H, Donohoe P, Ozer S, Bickler PE: Volatile anesthetics increase intracellular calcium in cerebrocortical and hippocampal neurons. Anesthesiology 1999; 90:1137–45

26. Madesh M, Hawkins BJ, Milovanova T, Bhanumathy CD, Joseph SK, Ramachandrarao SP, Sharma K, Kurosaki T, Fisher AB: Selective role for superoxide in InsP3 receptor-mediated mitochondrial dysfunction and endothelial apoptosis. J Cell Biol 2005; 170:1079–90

27. Chan SL, Mayne M, Holden CP, Geiger JD, Mattson MP: Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J Biol Chem 2000; 275:18195–200

28. Guo Q, Sopher BL, Furukawa K, Pham DG, Robinson N, Martin GM, Mattson MP: Alzheimer’s presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals. J Neurosci 1997; 17:4212–22

29. Guo Q, Furukawa K, Sopher BL, Pham DG, Xie J, Robinson N, Martin GM, Mattson MP: Alzheimer’s PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 1996; 8:379–83

30. Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME: Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 2000; 9:2799–809

31. Gines S, Ivanova E, Seong IS, Saura CA, MacDonald ME: Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington’s disease knock-in striatal cells. J Biol Chem 2003; 278:50514–22

32. Franks NP, Lieb WR: Temperature dependence of the potency of volatile general anesthetics: Implications for in vitro experiments. Anesthesiology 1996; 84:716–20

33. Hiroi T, Wei H, Hough C, Leeds P, Chuang DM: Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: Roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics J 2005; 5:102–11

34. Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260:3440–50

35. Camello C, Lomax R, Petersen OH, Tepikin AV: Calcium leak from intracellular stores: The enigma of calcium signalling. Cell Calcium 2002; 32:355–61

36. Stutzmann GE: Calcium dysregulation, IP3 signaling, and Alzheimer’s disease. Neuroscientist 2005; 11:110–5

37. Leissring MA, LaFerla FM, Callamaras N, Parker I: Subcellular mechanisms of presenilin-mediated enhancement of calcium signaling. Neurobiol Dis 2001; 8:469–78

38. Gafni J, Munsch JA, Lam TH, Catlin MC, Costa LG, Molinski TF, Pessah IN: Xestospongins: Potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron 1997; 19:723–33

39. Oka T, Sato K, Hori M, Ozaki H, Karaki H: Xestospongin C, a novel blocker of IP3 receptor, attenuates the increase in cytosolic calcium level and degranulation that is induced by antigen in RBL-2H3 mast cells. Br J Pharmacol 2002; 135:1959–66

40. De Smet P, Parys JB, Callewaert G, Weidema AF, Hill E, De Smedt H, Erneux C, Sorrentino V, Missiaen L: Xestospongin C is an equally potent inhibitor of the inositol 1,4,5-trisphosphate receptor and the endoplasmic-reticulum Ca2+ pumps. Cell Calcium 1999; 26:9–13

41. Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R, Kristal BS, Hayden MR, Bezprozvanny I: Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington’s disease. Proc Natl Acad Sci U S A 2005; 102:2602–7

42. Tang TS, Tu H, Orban PC, Chan EY, Hayden MR, Bezprozvanny I: HAP1 facilitates effects of mutant Huntingtin on inositol 1,4,5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons. Eur J Neurosci 2004; 20:1779–87

43. Pan JZ, Xi J, Tobias JW, Eckenhoff MF, Eckenhoff RG: Halothane binding proteome in human brain cortex. J Proteome Res 2007; 6:582–92

44. Matsuoka H, Kurosawa S, Horinouchi T, Kato M, Hashimoto Y: Inhalation anesthetics induce apoptosis in normal peripheral lymphocytes in vitro. Anesthesiology 2001; 95:1467–72

45. Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M: Induction of neuronal death by ER stress in Alzheimer’s disease. J Chem Neuroanat 2004; 28:67–78

46. Xie Z, Moir RD, Romano DM, Tesco G, Kovacs DM, Tanzi RE: Hypocapnia induces caspase-3 activation and increases Aβ production. Neurodegener Dis 2004; 1:29–37

47. Xie ZC, Romano DM, Kovacs DM, Tanzi RE: Effects of RNA interference-mediated silencing of gamma-secretase complex components on cell sensitivity to caspase-3 activation. J Biol Chem 2004; 279:34130–7

48. LaFerla FM: Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 2002; 3:862–72

49. Planel E, Richter KE, Nolan CE, Finley JE, Liu L, Wen Y, Krishnamurthy P, Herman M, Wang L, Schachter JB, Nelson RB, Lau LF, Duff KE: Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 2007; 27:3090–7

50. Kato R, Foex P: Myocardial protection by anesthetic agents against ischemia-reperfusion injury: An update for anesthesiologists. Can J Anaesth 2002; 49:777–91

51. Warner DS: Pharmacologic protection from ischemic neuronal injury. J Neurosurg Anesthesiol 2004; 16:95–7

52. Zuo Z, Wang Y, Huang Y: Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur J Pharmacol 2006; 542:84–91

53. Bickler PE, Zhan X, Fahlman CS: Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: Role of intracellular Ca2+ and mitogen-activated protein kinase signaling. Anesthesiology 2005; 103:532–9

54. Bickler PE, Fahlman CS: The inhaled anesthetic, isoflurane, enhances Ca2+-dependent survival signaling in cortical neurons and modulates MAP kinases, apoptosis proteins and transcription factors during hypoxia. Anesth Analg 2006; 103:419–29

55. Boyce M, Yuan J: Cellular response to endoplasmic reticulum stress: A matter of life or death. Cell Death Differ 2006; 13:363–73

56. Xu C, Bailly-Maitre B, Reed JC: Endoplasmic reticulum stress: Cell life and death decisions. J Clin Invest 2005; 115:2656–64

57. Wei H, Liang G, Yang H: Isoflurane preconditioning inhibited isoflurane-induced neurotoxicity. Neurosci Lett 2007; 425:59–62

58. Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M, Yoneshima H, Miyawaki A, Fukuuchi Y, Furuichi T, Okano H, Mikoshiba K, Noda T: Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 1996; 379:168–71

59. Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, Kitaguchi T, Takahashi-Iwanaga H, Noda T, Aruga J, Mikoshiba K: IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 2005; 309:2232–4

Cited By:

This article has been cited 26 time(s).

British Journal of Anaesthesia
Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis?
Heaney, A; Buggy, DJ
British Journal of Anaesthesia, 109(): I17-I28.
British Journal of Anaesthesia
Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells
Zhang, L; Zhang, J; Yang, L; Dong, Y; Zhang, Y; Xie, Z
British Journal of Anaesthesia, 110(): 82-91.
Journal of Biological Chemistry
The Mitochondrial Pathway of Anesthetic Isoflurane-induced Apoptosis
Zhang, YY; Dong, YL; Wu, X; Lu, Y; Xu, ZP; Knapp, A; Yue, Y; Xu, TJ; Xie, ZC
Journal of Biological Chemistry, 285(6): 4025-4037.
Neurotoxicity Research
Neurodegeneration in Newborn Rats Following Propofol and Sevoflurane Anesthesia
Bercker, S; Bert, B; Bittigau, P; Felderhoff-Muser, U; Buhrer, C; Ikonomidou, C; Weise, M; Kaisers, UX; Kerner, T
Neurotoxicity Research, 16(2): 140-147.
Pediatric Research
Anesthesia-Induced Neurodegeneration in Fetal Rat Brains
Wang, SP; Peretich, K; Zhao, YF; Liang, G; Meng, QC; Wei, HF
Pediatric Research, 66(4): 435-440.

Journal of Neuroscience
Isoflurane-induced caspase-3 activation is dependent on cytosolic calcium and can be attenuated by memantine
Zhang, GH; Dong, YL; Zhang, B; Ichinose, F; Wu, X; Culley, DJ; Crosby, G; Tanzi, RE; Xie, ZC
Journal of Neuroscience, 28(): 4551-4560.
Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer's disease
Fodale, V; Santamaria, LB; Schifilliti, D; Mandal, PK
Anaesthesia, 65(4): 388-395.
Current Alzheimer Research
Anesthesia, Calcium Homeostasis and Alzheimer's Disease
Wei, HF; Xie, ZC
Current Alzheimer Research, 6(1): 30-35.

Journal of Cerebral Blood Flow and Metabolism
Isoflurane anesthesia induced persistent, progressive memory impairment, caused a loss of neural stem cells, and reduced neurogenesis in young, but not adult, rodents
Zhu, CL; Gao, JF; Karlsson, N; Li, Q; Zhang, Y; Huang, ZH; Li, HF; Kuhn, HG; Blomgren, K
Journal of Cerebral Blood Flow and Metabolism, 30(5): 1017-1030.
Journal of Alzheimers Disease
Anesthesia with Isoflurane Increases Amyloid Pathology in Mice Models of Alzheimer's Disease
Perucho, J; Rubio, I; Casarejos, MJ; Gomez, A; Rodriguez-Navarro, JA; Solano, RM; De Yebenes, JG; Mena, MA
Journal of Alzheimers Disease, 19(4): 1245-1257.
Medical Hypotheses
Ketamine: The best partner for isoflurane in neonatal anesthesia?
Xiang, Q; Tan, L; Zhao, YL; Wang, JT; Luo, AL
Medical Hypotheses, 71(6): 868-871.
Anesthesia and Analgesia
Consensus Statement: First International Workshop on Anesthetics and Alzheimer's Disease
Baranov, D; Bickler, PE; Crosby, GJ; Culley, DJ; Eckenhoff, MF; Eckenthoff, RG; Hogan, KJ; Jevtovic-Todorovic, V; Palotas, A; Perouansky, M; Planel, E; Silverstein, JH; Wei, HF; Whittington, RA; Xie, ZC; Zuo, ZY
Anesthesia and Analgesia, 108(5): 1627-1630.
Journal of Pharmacology and Experimental Therapeutics
Anesthetic-Induced Neurodegeneration Mediated via Inositol 1,4,5-Trisphosphate Receptors
Zhao, YF; Liang, G; Chen, QR; Joseph, DJ; Meng, QC; Eckenhoff, RG; Eckenhoff, MF; Wei, HF
Journal of Pharmacology and Experimental Therapeutics, 333(1): 14-22.
Brain Research
Enhanced hypoxic preconditioning by isoflurane: Signaling gene expression and requirement of intracellular Ca2+ and inositol triphosphate receptors
Bickler, PE; Fahlman, CS
Brain Research, 1340(): 86-95.
Anesthesia and Analgesia
Anesthesia and the Old Brain
Tang, JX; Eckenhoff, MF; Eckenhoff, RG
Anesthesia and Analgesia, 110(2): 421-426.
International Journal of Clinical and Experimental Medicine
Halothane increases neuronal cell death vulnerability by downregulating miR-214 and upregulating Bax
Zhang, L; Zhang, Y
International Journal of Clinical and Experimental Medicine, 6(6): 452-460.

Halogenated volatile anesthetics alter brain metabolism as revealed by proton magnetic resonance spectroscopy of mice in vivo
Boretius, S; Tammer, R; Michaelis, T; Brockmoller, J; Frahm, J
Neuroimage, 69(): 244-255.
Plos One
Isoflurane Increases Neuronal Cell Death Vulnerability by Downregulating miR-214
Yan, HL; Xu, T; Zhao, HF; Lee, KC; Wang, HY; Zhang, Y
Plos One, 8(2): -.
ARTN e55276
International Journal of Molecular Medicine
Resveratrol mitigates isoflurane-induced neuroapoptosis by inhibiting the activation of the Akt-regulated mitochondrial apoptotic signaling pathway
Bai, T; Dong, DS; Pei, L
International Journal of Molecular Medicine, 32(4): 819-826.
Isoflurane Causes Greater Neurodegeneration Than an Equivalent Exposure of Sevoflurane in the Developing Brain of Neonatal Mice
Liang, G; Ward, C; Peng, J; Zhao, Y; Huang, B; Wei, H
Anesthesiology, 112(6): 1325-1334.
PDF (923) | CrossRef
Anesthetic Sevoflurane Causes Neurotoxicity Differently in Neonatal Naïve and Alzheimer Disease Transgenic Mice
Lu, Y; Wu, X; Dong, Y; Xu, Z; Zhang, Y; Xie, Z
Anesthesiology, 112(6): 1404-1416.
PDF (1752) | CrossRef
Inhalational Anesthetics Induce Cell Damage by Disruption of Intracellular Calcium Homeostasis with Different Potencies
Yang, H; Liang, G; Hawkins, BJ; Madesh, M; Pierwola, A; Wei, H
Anesthesiology, 109(2): 243-250.
PDF (785) | CrossRef
We Care, Therefore We Are: Anesthesia-related Morbidity and Mortality: The 46th Rovenstine Lecture
Cottrell, JE
Anesthesiology, 109(3): 377-388.
PDF (1852) | CrossRef
Nitrous Oxide Plus Isoflurane Induces Apoptosis and Increases β-Amyloid Protein Levels
Zhen, Y; Dong, Y; Wu, X; Xu, Z; Lu, Y; Zhang, Y; Norton, D; Tian, M; Li, S; Xie, Z
Anesthesiology, 111(4): 741-752.
PDF (816) | CrossRef
Neurotoxicity of General Anesthetics: Cause for Concern?
Perouansky, M; Hemmings, HC
Anesthesiology, 111(6): 1365-1371.
PDF (347) | CrossRef
Current Opinion in Anesthesiology
Update on inhalational anaesthetics
De Hert, SG; Preckel, B; Schlack, WS
Current Opinion in Anesthesiology, 22(4): 491-495.
PDF (112) | CrossRef
Back to Top | Article Outline

© 2008 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.

Article Tools